Mutares AG
Monday, 22 June 2015![](/assets/components/images/ourExperience/news_1435850907_6212.png)
ByrneWallace advised Munich-based restructuring specialist Mutares AG in relation to the sale of pharmaceutical contract manufacturer Suir Pharma Ireland to Slovakian based Saneca Pharmaceuticals. Suir Pharma operates as a Contract Manufacturing Organisation producing finished dosage formulations across a board range of therapeutic areas for various customers worldwide and operates the only Independent Beta-Lactam FDA approved facility in Europe.